Ospedale SS.Annunziata
Welcome,         Profile    Billing    Logout  
 4 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bonomini, Mario
Elixir, NCT03994471: Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

Recruiting
3
170
Europe
XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght, XyloCore 0.7 or 1.5 or 2.0, 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution, Physioneal 40 or 35, Fixioneal 40 or 35, Dianeal, Balance, Bicavera, Bicanova, Equibalance
Iperboreal Pharma Srl
End Stage Renal Disease
12/24
12/24
NCT04001036: Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

Terminated
2
11
Europe
1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, IPX15, 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, IPX07
Iperboreal Pharma Srl
End Stage Renal Disease
08/22
08/22
NCT04086212: Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

Withdrawn
2
10
NA
Icodextrin, xylitol and carnitine solution for peritoneal dialysis, IXC, EXTRANEAL 7.5G/100Ml Peritoneal Dialysis Solution, icodextrin
Iperboreal Pharma Srl
End Stage Renal Disease (ESRD)
12/22
04/23
PURE, NCT03994874: Peritoneal Ultrafiltration in Cardio Renal Syndrome.

Not yet recruiting
1/2
84
Europe
PolyCore (Polydextrin, L-Carnitine, D-xylitol), PolyCore peritoneal dialysis solution
Iperboreal Pharma Srl
Congestive Heart Failure
11/25
03/26

Download Options